Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Down 73.3% in March
by Sarita Garza · The Markets DailyRevolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report) saw a significant decrease in short interest in the month of March. As of March 31st, there was short interest totaling 725 shares, a decrease of 73.3% from the March 15th total of 2,716 shares. Based on an average daily volume of 11,394 shares, the short-interest ratio is currently 0.1 days.
Revolution Medicines Stock Performance
Shares of Revolution Medicines stock traded up $0.07 during trading on Friday, reaching $1.91. 292,087 shares of the stock were exchanged, compared to its average volume of 91,141. The stock’s fifty day moving average is $1.76 and its 200 day moving average is $1.24. Revolution Medicines has a 1 year low of $0.03 and a 1 year high of $3.59.
About Revolution Medicines
Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.
Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.